Epoprostenol Sodium

CAS 61849-14-7C20H31NaO5MW 374.4

Epoprostenol Sodium (CAS 61849-14-7) — formula C20H31NaO5, molecular weight 374.4; category inorganic chemicals.

Product Overview

CAS Number	61849-14-7
Molecular Formula	C20H31NaO5
Molecular Weight	374.4
Category	Inorganic Chemicals

Technical Profile

What this product is

Epoprostenol Sodium is an inorganic compound with CAS registry number 61849-14-7 and molecular formula C20H31NaO5 (molecular weight 374.4), belonging to the inorganic chemicals segment of chemical raw materials.

Identification

CAS number: 61849-14-7

Its molecular formula C20H31NaO5 comprises 20 C, 31 H, 1 Na, 5 O atoms.

Also known as: Epoprostenol Sodium · 依前列醇钠

Category: inorganic chemicals

Frequently Asked Questions

What is the CAS number of Epoprostenol Sodium?

The CAS registry number of Epoprostenol Sodium is 61849-14-7.

What is the molecular formula and molecular weight of Epoprostenol Sodium?

Molecular formula C20H31NaO5, molecular weight 374.4.

What other names is Epoprostenol Sodium known by?

It is also registered under: Epoprostenol Sodium, 依前列醇钠.

Which category does Epoprostenol Sodium belong to?

Category: Inorganic Chemicals.

PubChem Public Data

Independent reference data for Epoprostenol Sodium (CAS 61849-14-7), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number	61849-14-7
PubChem CID	6364626
Molecular formula	C20H31NaO5
IUPAC name	sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
UNII (FDA)	4K04IQ1OF4

Computed descriptors

Molecular Weight	374.4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	10
Exact Mass	374.20691837
Monoisotopic Mass	374.20691837
Topological Polar Surface Area	89.8
Heavy Atom Count	26

Documented uses on record

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Synonyms and trade names

Epoprostenol sodium; 61849-14-7; Prostacyclin sodium salt; Cyclo-Prostin; Sodium prostacyclin; DTXSID3046617; 4K04IQ1OF4; U-53217A; U-53,217A; DTXCID1026617; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-; RefChem:57240; 263-273-7; Flolan; Prostacyclin sodium; C20H31NaO5

GHS hazard classification

Reported hazard statements	H302 (97.4%), H312 (97.4%), H332 (97.4%)

H302 (97.4%): Harmful if swallowed [Warning Acute toxicity, oral]

H312 (97.4%): Harmful in contact with skin [Warning Acute toxicity, dermal]

What the public record says

Epoprostenol Sodium · CAS 61849-14-7 · C20H31NaO5. UNII 4K04IQ1OF4.

Source: PubChem / Wikidata; the batch COA governs where values differ.

Epoprostenol Sodium

Product Overview

Technical Profile

What this product is

Identification

Frequently Asked Questions

PubChem Public Data

Registry identifiers across databases

Computed descriptors

Documented uses on record

Synonyms and trade names

GHS hazard classification

What the public record says

Related Products

Ammonium bromide

Aluminium stearate

Acetic acid,sodium salt trihydrate

Albuterol sulfate

Aluminum fluoride

Ammonium thiosulfate

Aluminium Oxide

atropine sulphate

Request a Quote